Biotech takes Trump presidency as a green light — and end to drug price worries

The difference since last week is “dramatic,” a biotech portfolio manager said.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.